Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$371M |
| 2 |
Intuit
INTU
|
+$370M |
| 3 |
AbbVie
ABBV
|
+$366M |
| 4 |
Netflix
NFLX
|
+$321M |
| 5 |
ICU Medical
ICUI
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$673M |
| 2 |
Apple
AAPL
|
+$561M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$560M |
| 4 |
American Tower
AMT
|
+$532M |
| 5 |
Meta Platforms (Facebook)
META
|
+$424M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 17.85% |
| 3 | Financials | 12.82% |
| 4 | Industrials | 11.65% |
| 5 | Consumer Discretionary | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
BWX Technologies
BWXT
$16.2B
| $75.6M | 0.05% |
1,977,701
+166,691
| +9% | +$8.28M |
|
427
Rollins
ROL
$18.8B
| $75.5M | 0.05% |
3,137,879
+1,703,774
| +119% | +$44M |
|
428
Cheniere Energy
LNG
$53.6B
| $75.5M | 0.05% |
1,275,684
+298,478
| +31% | +$18.4M |
|
429
Burlington
BURL
$22.5B
| $75.5M | 0.05% |
464,092
+176,858
| +62% | +$28.6M |
|
|
MRO
430
DELISTED
Marathon Oil Corporation
MRO
| $75.5M | 0.05% |
5,264,103
+890,391
| +20% | +$15.9M |
|
431
Lamb Weston
LW
$7.3B
| $75.4M | 0.05% |
1,025,673
-225,361
| -18% | -$17.3M |
|
432
Kosmos Energy
KOS
$1.45B
| $75.3M | 0.05% |
18,570,000
+3,040,000
| +20% | +$18.8M |
|
433
LendingTree
TREE
$564M
| $75.1M | 0.05% |
342,067
+17,211
| +5% | +$3.91M |
|
|
CISN
434
DELISTED
Cision Ltd. Ordinary Share
CISN
| $74.7M | 0.05% |
6,381,852
+3,704,028
| +138% | +$50.6M |
|
435
NeoGenomics
NEO
$1.71B
| $74.3M | 0.05% |
5,888,667
-215,808
| -4% | -$3.22M |
|
|
XEC
436
DELISTED
CIMAREX ENERGY CO
XEC
| $74.1M | 0.05% |
1,201,569
+85,178
| +8% | +$6.99M |
|
437
Nomad Foods
NOMD
$1.67B
| $74M | 0.05% |
4,427,646
+8,878
| +0.2% | +$169K |
|
438
Universal Health Services
UHS
$9.64B
| $73.5M | 0.05% |
630,620
+5,852
| +0.9% | +$736K |
|
|
EGRX
439
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $72.3M | 0.05% |
1,795,462
-86,039
| -5% | -$4.43M |
|
440
Generac Holdings
GNRC
$11.6B
| $71.3M | 0.05% |
1,434,892
-222,798
| -13% | -$11.9M |
|
441
Collegium Pharmaceutical
COLL
$1.15B
| $71.3M | 0.05% |
4,151,719
+31,896
| +0.8% | +$546K |
|
442
CGI
GIB
$14.5B
| $70.9M | 0.05% |
1,159,108
+626,237
| +118% | +$38.6M |
|
443
Conagra Brands
CAG
$7.29B
| $70.5M | 0.05% |
3,301,914
+1,091,137
| +49% | +$35.3M |
|
444
Dorman Products
DORM
$4.08B
| $70.4M | 0.04% |
782,451
-9,321
| -1% | -$745K |
|
445
Goldman Sachs
GS
$309B
| $70.4M | 0.04% |
421,351
-313,276
| -43% | -$63.2M |
|
446
Sempra
SRE
$59.7B
| $69.9M | 0.04% |
1,292,574
+563,062
| +77% | +$32.1M |
|
447
AMC Entertainment Holdings
AMC
$2.24B
| $69.7M | 0.04% |
567,234
+90,461
| +19% | +$14.8M |
|
|
JWN
448
DELISTED
Nordstrom
JWN
| $69.4M | 0.04% |
1,487,948
+1,239,905
| +500% | +$69.9M |
|
449
Wave Life Sciences
WVE
$1.14B
| $69M | 0.04% |
1,641,194
+124,414
| +8% | +$5.53M |
|
450
Ironwood Pharmaceuticals
IRWD
$644M
| $68.9M | 0.04% |
7,945,838
-1,590,371
| -17% | -$18.3M |
|
Similar funds
Janus Henderson Group's Q4 2018 Portfolio in Review
As of Q4 2018, Janus Henderson Group held 1,484 positions worth $157B, down 16% from $187B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q4 2018 filing shows 42 new, 623 increased, 625 reduced and 154 closed positions. Its largest new stake was Frontdoor: 6,881,191 shares worth $183M. The largest sale was Aetna Inc, an estimated $673M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2018 buy was Frontdoor: 6,881,191 shares worth $183M.
- Janus Henderson Group added most to Microsoft in Q4 2018, an estimated $371M increase.
- Janus Henderson Group's biggest Q4 2018 reduction was Apple, cutting an estimated $561M.
- Janus Henderson Group fully exited Aetna Inc in Q4 2018, selling an estimated $673M.
- Janus Henderson Group's ten largest holdings make up 17% of its $157B portfolio in Q4 2018.
- Janus Henderson Group opened 42 new positions and closed 154 in Q4 2018.
- Janus Henderson Group's portfolio value fell 16% quarter-over-quarter to $157B.
Based on Janus Henderson Group's 13F filing for Q4 2018, filed 6 Feb 2019.